Posted in Clinical Data Roche to start new Elevidys study following setback in Europe April 16, 2026 BioPharma Dive The Swiss drugmaker, which owns rights to the Duchenne gene therapy outside the U.S., hopes the trial will yield additional approvals in Europe and elsewhere. Clinical DataNeuroscienceRead full story